Reduced Lipoprotein(a) Associated With the Apolipoprotein E2 Genotype Confers Cardiovascular Protection in Familial Hypercholesterolemia - Groupe d'Etude sur l'Inflammation Chronique et l'Obésité Accéder directement au contenu
Article Dans Une Revue JACC : Basic to Translational Science Année : 2019

Reduced Lipoprotein(a) Associated With the Apolipoprotein E2 Genotype Confers Cardiovascular Protection in Familial Hypercholesterolemia

Résumé

There are 3 isoforms of apolipoprotein E (apo E) in humans (ε2, ε3, and ε4). They differ by single amino acid substitutions that variably affect their affinity for the low-density lipoprotein receptor (LDLR) and for the LDLR-related protein (LRP1), with ε2 having the weakest binding to these receptors (1). The plasma levels of lipoprotein(a) [Lp(a)], a highly atherogenic LDL-like lipoprotein species, are influenced by the polymorphism of apo E, with ε2/ε2 and ε4/ε4 carriers presenting with the lowest and highest Lp(a) plasma concentrations, respectively (1).
Fichier principal
Vignette du fichier
33 - Blanchard et al, JACC Basic Transl Sci, 2019.pdf (456.41 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-02429499 , version 1 (06-01-2020)

Licence

Paternité - Pas de modifications

Identifiants

Citer

Valentin Blanchard, Mikael Croyal, Ilya Khantalin, Stéphane Ramin-Mangata, Kévin Chemello, et al.. Reduced Lipoprotein(a) Associated With the Apolipoprotein E2 Genotype Confers Cardiovascular Protection in Familial Hypercholesterolemia. JACC : Basic to Translational Science, 2019, 4 (3), pp.425-427. ⟨10.1016/j.jacbts.2019.03.002⟩. ⟨hal-02429499⟩
98 Consultations
48 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More